Robot model
CORI
The CORI Surgical System is Smith+Nephew's compact, surgeon-controlled handheld robotics platform for orthopedic knee surgery, recorded in the surgical form…
- Manufacturer
- Smith+Nephew
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 1
- Website
- smith-nephew.com ↗
Overview
The CORI Surgical System is Smith+Nephew's compact, surgeon-controlled handheld robotics platform for orthopedic knee surgery, recorded in the surgical form factor as the handheld, imageless, smaller-footprint archetype of the orthopedic sub-cohort. Unlike Stryker's Mako, which uses a pre-operative CT scan and a large robotic arm, CORI is imageless: the surgeon paints the joint surface intra-operatively to build a three-dimensional bone model, then uses a handheld robotic bur whose cutting speed and exposure are robotically controlled to the surgical plan, with optical navigation via a passive infrared camera that Smith+Nephew states is four times faster with twice the cutting volume of the prior NAVIO system. Because the surgeon physically holds and moves the tool throughout while the software does the imageless mapping, planning, and intra-operative tracking that governs the bur, CORI is AI-augmented surgeon-controlled assistance and not autonomous, and it is in scope as a surgical robot. Made by Smith+Nephew, listed as SN in London and SNN in New York, the system descends from Smith+Nephew's October 2015 acquisition of Blue Belt Technologies for 275 million dollars, whose NAVIO handheld system evolved into CORI at its July 14, 2020 launch alongside the Real Intelligence platform. Its robotic-cutting scope is cleared for total, partial or unicompartmental, and revision knee, with revision knee a 2022 first-to-market indication on a robotics platform; its hip capability is navigation only, through RI.HIP NAVIGATION cleared in January 2022, and is not robotic burring, a distinction several secondary sources blur. The platform is positioned for ambulatory surgery centers and outpatient operating rooms, and no CORI-specific installed-base or procedure-volume figure is asserted here because none was verified against Smith+Nephew investor disclosure.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- 1 deployment on file
- Sources on file
- 7 sources, view all
Key facts
Form factor
Autonomy level
Imaging
Cleared knee scope
Hip capability
Camera speed
Cutting volume
Launch date
Acquisition
Specs
Notes
Specs
Form Factor
Visualization
Procedure types
Data & sources
Company filings
1
Research
1
Web sources
5
7 sources backing this record.View all →
Availability and pricing
- Availability
- Not sold (internal use)
- Price
- $600K to $1.2M (analyst estimate)as of 2025-01-01
- Units in field
- Not disclosed
- Sales model
- Not disclosed
- Lead time
- Not disclosed
Pricing
One-time purchase
$600,000 - $1,200,000 USDanalyst estimateas of 2025-01-01
Source: How Much is a Surgical Robot? (2025 Edition) – R2 Surgical
Price status: actual-sale-price = real published price at time of sale; manufacturer-target = vendor target, not yet realized; analyst-estimate = third-party projection, not a vendor figure; not-announced = no price on record.
Prices verified as of Jan 1, 2025
Deployments (1)
- CORI at United Statesoperational
The CORI Surgical System received FDA 510(k) clearance (K212047) in October 2021 for use in the United States.
CORI on the deployment map
Where CORI is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 5, 2026
Smith+Nephew CORI Surgical System
- Record createdJun 4, 2026
Added to the verified registry
- Price point recorded: $600,000-$1,200,000Jan 1, 2025
Analyst estimate
- Deployment verifiedVerifiedOct 1, 2021
at United States
Deployment-verified media (1)
Smith+Nephew's overview of its CORI handheld robotic surgery system (distinct from the older NAVIO). The surgeon holds and moves the tool; robotic control auto-stops the burr outside the planned zone.
From deployment: United States
Regulatory filings (1)
- fda_510kfda 510k · us_fdacleared2020-01-01
Applicant: Smith+Nephew
Safety record
No incidents on record for CORI.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (7)
- https://www.smith-nephew.com/en/news/2015/10/29/20151029-acquisition-of-blue-belt-technologies
- https://www.smith-nephew.com/en/news/2020/07/14/20200714-sn-launches-real-intelligence-and-cori-surgical-system
- https://www.smith-nephew.com/en/news/2022/01/26/20220126-expands-next-generation-handheld-robotic-assisted-cori-surgical-system-into-total-hip
- https://www.prnewswire.com/news-releases/smithnephew-first-to-market-with-revision-knee-indication-on-robotics-platform-301632322.html
- https://pubmed.ncbi.nlm.nih.gov/36837438/
- https://link.springer.com/article/10.1007/s11701-026-03198-8
- https://www.sec.gov/Archives/edgar/data/0000845982/000119163815001277/sn201510296k.htm
Compare CORI
Common questions
- What is CORI?
- The CORI Surgical System is Smith+Nephew's compact, surgeon-controlled handheld robotics platform for orthopedic knee surgery, recorded in the surgical form factor as the handheld, imageless, smaller-footprint archetype of the orthopedic sub-cohort. Unlike Stryker's Mako, which uses a pre-operative CT scan and a large robotic arm, CORI is imageless: the surgeon paints the joint surface intra-operatively to build a three-dimensional bone model, then uses a handheld robotic bur whose cutting speed and exposure are robotically controlled to the surgical plan, with optical navigation via a passive infrared camera that Smith+Nephew states is four times faster with twice the cutting volume of the prior NAVIO system. Because the surgeon physically holds and moves the tool throughout while the software does the imageless mapping, planning, and intra-operative tracking that governs the bur, CORI is AI-augmented surgeon-controlled assistance and not autonomous, and it is in scope as a surgical robot. Made by Smith+Nephew, listed as SN in London and SNN in New York, the system descends from Smith+Nephew's October 2015 acquisition of Blue Belt Technologies for 275 million dollars, whose NAVIO handheld system evolved into CORI at its July 14, 2020 launch alongside the Real Intelligence platform. Its robotic-cutting scope is cleared for total, partial or unicompartmental, and revision knee, with revision knee a 2022 first-to-market indication on a robotics platform; its hip capability is navigation only, through RI.HIP NAVIGATION cleared in January 2022, and is not robotic burring, a distinction several secondary sources blur. The platform is positioned for ambulatory surgery centers and outpatient operating rooms, and no CORI-specific installed-base or procedure-volume figure is asserted here because none was verified against Smith+Nephew investor disclosure.
- How much does CORI cost?
- CORI is listed at $600,000 to $1,200,000 on the DEPLOY registry. This is an analyst estimate, not an official price.
- Is CORI actually deployed in the real world?
- Yes. CORI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
- Is CORI autonomous or teleoperated?
- Not verified as fully autonomous. CORI's capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Assists surgery), not independently confirmed to run without a human in the loop.
- Who makes CORI?
- CORI is made by Smith+Nephew, based in Watford, England, UK, founded in 1856.
- Where is CORI deployed?
- 1 verified deployment of CORI is on the DEPLOY registry, including at United States.
- Can you buy CORI?
- CORI is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- Is CORI FDA cleared?
- CORI has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.
- What are alternatives to CORI?
- On the DEPLOY registry, comparable surgical robots to CORI include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does CORI compare to Toumai?
- CORI and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. CORI has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- Is CORI a top surgical?
- On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, CORI ranks in roughly the top 40% of surgical models tracked by the registry.
- What is CORI's maturity stage?
- CORI is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Is CORI safe?
- CORI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
- What is the Smith Nephew CORI surgical robot?
- The Smith Nephew CORI Surgical System is a handheld robotic platform for orthopedic surgery, designed for accuracy in bone resection and alignment. It is the first system indicated for robotic-assisted revision knee surgery. The CORI XT is the next-generation platform for all orthopedic needs from partial to revision knee, hip, and shoulder.
Methodology: Aggregator drift detected · 7 sources (2 primary) · last reviewed 2026-07-12
Verification posture
Aggregator drift detected
Cap-flag required
Review state
Drift-flagged
Last reviewed 2026-07-12
1 anchored drift pattern(s); see cap_flags
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 5
- unclassified
- Unclassified source
- 1
- primary-academic-peer-reviewed
- Peer-reviewed clinical / academic
- 1
- primary-sec-filing
- SEC filing
Canonical worked example pair
Surgical orthopedic robot sub-cohort triangle
This entity is the knee-robotic / hip-navigation-only anchor on within-cohort-verified-vs-claimed-pair.
Pairs with: stryker-mako, zimmer-biomet-rosa
Cap flags
Claim: Smith+Nephew CORI's hip capability is robotic
Honest status: CORI's hip capability is navigation-only, not robotic. Only knee is robotic on CORI. Hip-as-robotic claims are aggregator capability overstating.
CORI hip is navigation-only. Only knee is robotic on CORI.
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for CORI.Recent coverage
CORI in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning CORI from third-party publications. Automatically surfaced; not part of the verified registry record.
SK Hynix Shares Rebound After Early Rout as AI Jitters Persist
SK Hynix Inc. erased an early plunge to climb more than 3% in Seoul on Tuesday, underscoring the extreme volatility gripping one of the world’s biggest beneficiaries of the…
Class 8 truck orders soar 241% as fleets race to secure 2026 build slots
North American Class 8 truck orders jumped 241% year over year in June, underscoring rising fleet demand. The post Class 8 truck orders soar 241% as fleets race to secure 2026…
SK Hynix US Listing Is Seven Times Oversubscribed
SK Hynix Inc.’s US offering is more than seven times oversubscribed, according to people familiar with the matter, underscoring strong investor appetite despite recent volatility…
SK Hynix US Offering Is More Than Seven Times Oversubscribed
SK Hynix Inc.’s US listing is more than seven times oversubscribed, according to people familiar with the matter, underscoring strong investor appetite despite recent volatility…
AI Chip Startup Raises Funds at $11B Valuation
Bloomberg's Ryan Gould joins Dani Burger on "Bloomberg Deals." Chip startup SambaNova has raised $1 billion at an $11 billion valuation, underscoring investors’ conviction in…
Incredible Demand for Inferencing at High Speeds: SambaNova CEO
Chip startup SambaNova raised $1 billion at an $11 billion valuation, underscoring investors’ conviction in rising demand for infrastructure tied to AI. SambaNova CEO Rodrigo…
AI Chip Startup SambaNova Raises Funds at $11 Billion Value
Chip startup SambaNova Systems Inc. has raised $1 billion at an $11 billion valuation, underscoring investors’ conviction in rising demand for infrastructure tied to artificial…
Chinese Firms Leave Nvidia for Local AI Suppliers, Survey Shows
Chinese companies are ditching Nvidia Corp.’s advanced accelerators in favor of domestic silicon, underscoring how tensions with the US are reshaping the AI infrastructure…
Vertiv Opens Malaysia Plant to Meet AI Data Centers’ Power Needs
US data center equipment maker Vertiv Holdings Co. opened a factory in Malaysia, underscoring the rapid pace of AI infrastructure buildout in the Asia Pacific.
China, India See Top Firms Lose Market Cap Share in AI Lag
China, India, and Hong Kong have emerged as the only major stock markets worldwide where top companies account for a smaller share of market capitalization than a year ago,…
Romania bolsters Black Sea fleet with Turkish-built corvette
The transfer marks the first delivery of a Turkish-built warship to a European Union and NATO member state, underscoring Turkey’s growing naval exports.
Smith+Nephew announces first clinical cases with the next generation CORI XT Handheld Robotics Platform across knee and shoulder arthroplasty
Smith+Nephew completes first clinical cases using CORI XT handheld robotic platform for knee and shoulder arthroplasty at Duke Health.
Machine-readable surfaces
- Markdown mirror: /models/smith-nephew-cori.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/27b307aa-b48d-4f91-9156-fbea01c0736f
- Revision history: /models/smith-nephew-cori/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Buyer-facing pricing: deploy.report/price/smith-nephew-cori
Reality vs attention
CORI draws attention at the 71st percentile but verifies reality at the 23rd percentile among surgical robots. Hype Gap +48.7, 4th widest among surgical robots.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 19, 2026